Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.

Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.

We report a young woman with the abrupt onset of infectious mononucleosis due to Epstein-Barr virus associated with a subsequent autoimmune form of diabetes mellitus and myasthenia gravis with anti-muscle-specific kinase (MuSK) antibodies. The simultaneous onset of these two autoimmune diseases prec...

Descripció completa

Dades bibliogràfiques
Autors principals:	Bhibhatbhan, A, Kline, G, Vincent, A, Toth, C
Format:	Journal article
Idioma:	English
Publicat:	2007

Ítems similars

Myasthenia gravis with MuSK antibodies
per: Farrugia, M, et al.
Publicat: (2005)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
per: Koneczny, I, et al.
Publicat: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
per: Koneczny, I, et al.
Publicat: (2014)

Potential mechanisms in MuSK-myasthenia gravis
per: Koneczny, I
Publicat: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
per: Shalini Bhaskar, et al.
Publicat: (2022-01-01)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
per: Vincent, A, et al.
Publicat: (2006)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
per: J Gordon Millichap
Publicat: (2006-08-01)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
per: McConville, J, et al.
Publicat: (2004)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
per: Lee, J, et al.
Publicat: (2006)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
per: Nilesh Wagh, et al.
Publicat: (2024-09-01)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
per: Carmelo Rodolico, et al.
Publicat: (2020-07-01)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
per: Chang, T, et al.
Publicat: (2009)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
per: Phillips, W, et al.
Publicat: (2015)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
per: Newsom-Davis, J, et al.
Publicat: (2001)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
per: Bennett, D, et al.
Publicat: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
per: Diana Epure, et al.
Publicat: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
per: Ting LI, et al.
Publicat: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
per: Yung-Chuan Huang, et al.
Publicat: (2008-07-01)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
per: Dipesh Chhetri, et al.
Publicat: (2025-02-01)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
per: Yeh, J, et al.
Publicat: (2004)

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
per: Jamie L. Lim, et al.
Publicat: (2025-02-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
per: Shiraishi, H, et al.
Publicat: (2005)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
per: Cao, M
Publicat: (2021)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
per: Fangyi Shi, et al.
Publicat: (2024-11-01)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
per: Amber Eker, et al.
Publicat: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
per: Zunwei Zhang, et al.
Publicat: (2020-10-01)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
per: Lee, J, et al.
Publicat: (2016)

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
per: S. Lanfranconi, et al.
Publicat: (2011-01-01)

MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
per: Edyta Dziadkowiak, et al.
Publicat: (2024-03-01)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
per: Christiane Schneider-Gold, et al.
Publicat: (2017-10-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
per: Farrugia, M, et al.
Publicat: (2007)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
per: Deymeer, F, et al.
Publicat: (2007)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
per: Niks, E, et al.
Publicat: (2006)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
per: Farrugia, M, et al.
Publicat: (2006)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
per: Aigli G. Vakrakou, et al.
Publicat: (2023-07-01)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
per: Vuslat Yilmaz, et al.
Publicat: (2015-01-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
per: Shan CAO, et al.
Publicat: (2019-02-01)

MuSK Myasthenia Gravis in an HIV-infected Chinese old man successfully treated with pyridostigmine
per: Yirui Xie, et al.
Publicat: (2020-09-01)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
per: Hoch, W, et al.
Publicat: (2001)

Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis
per: Siripong Chayanopparat, et al.
Publicat: (2025-02-01)